NP-603

N/A

Report date: 2022/06/08 16:02:29
NME

Base Information

Drug NameNP-603
Drug Alias NameNP-603
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 1 antagonists
TargetsFibroblast growth factor receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMahidol University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMahidol University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A